Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

α4Gn-T Activators

The chemical class known as α4Gn-T, also known as A4GNT, activators encompasses a variety of compounds that can influence the activity of the enzyme alpha-1,4-N-acetylglucosaminyltransferase. Rather than acting as direct agonists, these chemicals can modify the cellular environment or the glycosylation pathways in which α4Gn-T operates. Their modes of action are diverse, reflecting the complex interplay between enzyme function and cellular processes. Some members of this class act by inhibiting other glycosylation pathways, which can lead to a compensatory increase in the activity of α4Gn-T as the cell attempts to maintain glycosylation homeostasis. Others interfere with the folding and processing of glycoproteins, which can indirectly upregulate the expression or activity of α4Gn-T as the cell responds to changes in glycoprotein structure and function.

Additionally, certain chemicals in this class are known to disrupt the function of the Golgi apparatus, where α4Gn-T is localized, thereby affecting its operation. Alterations in the Golgi apparatus can have broad implications for glycosylation enzymes, including α4Gn-T. Some activators work by influencing the cellular levels of key glycosylation substrates or by altering the signaling pathways that govern the expression of glycosylation enzymes. They can affect the availability of precursor molecules necessary for the enzymatic activity of α4Gn-T or modulate the intracellular signaling that regulates enzyme expression. Through these diverse actions, the chemicals classified as α4Gn-T activators can play a significant role in regulating the activity of this enzyme, thereby influencing the glycosylation patterns within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Inhibitor of N-linked glycosylation; could possibly activate A4GNT as a compensatory mechanism when O-glycosylation is upregulated.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$72.00
$142.00
(0)

Inhibitor of alpha-glucosidases; could possibly activate A4GNT by leading to glycoprotein misfolding and indirectly affecting function.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Adenylyl cyclase activator; raises intracellular cAMP levels, which could possibly activate glycosylation enzyme expression including A4GNT.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$65.00
$210.00
26
(2)

Analog of glucose; can interfere with glycolysis and could possibly activate glycosylation processes related to A4GNT activity.

Azaserine

115-02-6sc-29063
sc-29063A
50 mg
250 mg
$306.00
$906.00
15
(3)

Glutamine antagonist; could possibly activate glycosylation by limiting substrate availability for glycan synthesis, possibly influencing A4GNT.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$132.00
$529.00
$1005.00
$6125.00
25
(2)

Mannosidase I inhibitor; could possibly activate A4GNT by increasing misfolded glycoproteins and altering the function of glycosylation enzymes.